Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
37,778,373
-
Total 13F shares
-
33,154,047
-
Share change
-
+6,503,901
-
Total reported value
-
$1,649,828,469
-
Put/Call ratio
-
21%
-
Price per share
-
$49.64
-
Number of holders
-
155
-
Value change
-
+$313,979,403
-
Number of buys
-
98
-
Number of sells
-
51
Institutional Holders of Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) as of Q1 2025
As of 31 Mar 2025 Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) had 155 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 33,154,047 shares of stock of the company.
Largest 10 holders included FMR LLC, Atlas Venture Life Science Advisors, LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., Frazier Life Sciences Management, L.P., RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, ORBIMED ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, and VANGUARD GROUP INC.
This table shows 155 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.